About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Smarca4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
MGI:88192
87 phenotypes from 10 alleles in 16 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Nfatc1tm1(cre)Bz/Nfatc1+
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ 		abnormal aortic valve morphology J:226941
abnormal heart ventricle morphology J:226941
bicuspid aortic valve J:226941
cardiomyopathy J:226941
enlarged heart J:226941
normal mortality/aging J:226941
thick aortic valve cusps J:226941
thick pulmonary valve J:226941
Nfatc1tm1.1(cre)Bz/Nfatc1+
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ 		abnormal aortic sinus morphology J:226941
abnormal aortic valve cusp morphology J:226941
abnormal aortic valve morphology J:226941
abnormal cardiac outflow tract development J:226941
abnormal coronary artery morphology J:226941
abnormal coronary vein morphology J:226941
abnormal pulmonary valve cusp morphology J:226941
abnormal semilunar valve morphology J:226941
bicuspid aortic valve J:226941
enlarged heart J:226941
lethality throughout fetal growth and development, incomplete penetrance J:226941
perimembraneous ventricular septal defect J:226941
perinatal lethality J:226941
thick aortic valve J:226941
thick heart valve cusps J:226941
thick myocardium J:226941
thick pulmonary valve J:226941
Smarca4b2b508.1Clo/Smarca4b2b508.1Clo
C57BL/6J-Smarca4b2b508.1Clo 		anophthalmia J:175213
atrioventricular septal defect J:175213
complete atrioventricular septal defect J:175213
double outlet right ventricle J:175213
microcephaly J:175213
micrognathia J:175213
ventricular septal defect J:175213
Smarca4b2b692Clo/Smarca4b2b692Clo
C57BL/6J-Smarca4b2b692Clo 		coronary-cameral fistula to heart right ventricle J:175213
double outlet right ventricle J:175213
muscular ventricular septal defect J:175213
overriding aortic valve J:175213
perimembraneous ventricular septal defect J:175213
Smarca4enu1/Smarca4tm1Mag
involves: 129S/Sv * C57BL/10 * CBA/Cbi 		abnormal blood cell morphology/development J:103896
abnormal erythrocyte morphology J:103896
abnormal liver morphology J:103896
embryonic lethality during organogenesis, complete penetrance J:103896
Smarca4mos6/Smarca4mos6
involves: BALB/cJ * C57BL/6J 		embryonic lethality, complete penetrance J:241206
Smarca4tm1.1Axvi/Smarca4tm1.1Axvi
involves: 129S6/SvEvTac 		no abnormal phenotype detected J:212226
Smarca4tm1.1Grc/Smarca4tm1.1Grc
involves: 129 * C57BL/6 		no abnormal phenotype detected J:101977
Smarca4tm1.1Pcn/Smarca4+
involves: 129S2/SvPas * C57BL/6 * DBA/2 		cyanosis J:172661
patent ductus arteriosus J:172661
ventricular septal defect J:172661
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn
Tg(Myh11-cre,-EGFP)2Mik/0
involves: 129S2/SvPas * C57BL/6 * DBA/2 		abnormal intestinal smooth muscle morphology J:172661
abnormal jejunum morphology J:172661
abnormal muscle physiology J:172661
abnormal pulmonary circulation J:172661
abnormal small intestine morphology J:172661
congestive heart failure J:172661
cyanosis J:172661
decreased colon length J:172661
decreased small intestine length J:172661
dilated heart J:172661
enlarged cecum J:172661
enlarged ileum J:172661
impaired smooth muscle contractility J:172661
megacolon J:172661
patent ductus arteriosus J:172661
postnatal lethality, incomplete penetrance J:172661
primary atelectasis J:172661
pulmonary alveolar proteinosis J:172661
ventricular septal defect J:172661
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(KRT14-cre)1Ipc/?
involves: 129S2/SvPas * C57BL/6 * SJL 		abnormal apical ectodermal ridge morphology J:101729
abnormal digit morphology J:101729
abnormal epidermis stratum corneum morphology J:101729
abnormal hindlimb morphology J:101729
abnormal hindlimb zeugopod morphology J:101729
abnormal skin morphology J:101729
dry skin J:101729
impaired skin barrier function J:101729
monodactyly J:101729
neonatal lethality, complete penetrance J:101729
shiny skin J:101729
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(KRT14-cre/ERT2)1Ipc/?
involves: 129S2/SvPas 		abnormal digit morphology J:101729
abnormal epidermis stratum corneum morphology J:101729
abnormal hindlimb morphology J:101729
abnormal skin morphology J:101729
impaired skin barrier function J:101729
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
Not Specified 		abnormal T cell morphology J:144072
decreased double-negative T cell number J:144072
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Nfat1c-cre)1Bz/0
involves: 129S2/SvPas 		normal cardiovascular system phenotype J:226941
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Sox10-cre)1Wdr/0
involves: 129S2/SvPas * C57BL/6 * CBA 		abnormal melanoblast morphology J:241206
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Tek-cre)1Ywa/0
involves: 129S2/SvPas * C57BL/6 * SJL 		abnormal atrioventricular cushion morphology J:226941
abnormal cardiac outflow tract development J:226941
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
involves: 129S/Sv * C57BL/6 * DBA/2 		abnormal T cell differentiation J:85191
absent CD8-positive, alpha-beta T cells J:85191
arrested T cell differentiation J:85191
decreased CD4-positive, alpha-beta T cell number J:85191
decreased double-negative T cell number J:85191
decreased double-positive T cell number J:85191
thymus hypoplasia J:85191
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
involves: 129 		abnormal T cell morphology J:144072
decreased double-negative T cell number J:144072
decreased thymocyte number J:144072
Smarca4tm1Mag/Smarca4+
involves: 129S/Sv * C57BL/6J * CD-1 		increased mammary adenocarcinoma incidence J:132091
increased osteosarcoma incidence J:132091
Smarca4tm1Mag/Smarca4+
involves: 129S/Sv * CD-1 		decreased survivor rate J:66861
exencephaly J:66861
increased tumor incidence J:66861
postnatal lethality, incomplete penetrance J:66861
Smarca4tm1Mag/Smarca4tm1.2Pcn
involves: 129S2/SvPas 		normal cellular phenotype J:66861
Smarca4tm1Mag/Smarca4tm1Mag
involves: 129S/Sv * CD-1 		embryonic lethality before implantation, complete penetrance J:66861
Smarca4tm1Tich/Smarca4+
involves: 129 		normal immune system phenotype J:144072
Smarca4tm1Tich/Smarca4+
Tg(Lck-cre)1Cwi/0
involves: 129 		decreased double-negative T cell number J:144072
decreased double-positive T cell number J:144072
decreased single-positive T cell number J:144072
decreased thymocyte number J:144072
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory